Literature DB >> 1569089

Identification of a single base change in ribosomal RNA leading to erythromycin resistance.

P Vannuffel1, M Di Giambattista, E A Morgan, C Cocito.   

Abstract

The molecular basis of a mutation conferring an erythromycin-resistance phenotype was explored, as an approach to the role of 23 S rRNA in the peptidyl-transferase activity of 50 S ribosomal subunits. Mutagenization of an Escherichia coli strain, which carried the multicopy plasmid pLC7-21 containing the rrnH operon, led to the production of an erythromycin-resistant strain. Plasmid pBFL1 isolated from this mutant was able to transform the sensitive RecA- strain EM4 and to induce a "dissociated" type of antibiotic resistance. Two ribosome populations occurred in EM4/pBFL1: normal particles coded for by the seven rrn chromosomal genes and mutated particles containing rRNA of plasmid origin. The latter particles displayed in vitro lower affinity and susceptibility to erythromycin than wild type particles. The mutation within plasmid pBFL1 was mapped by a multiple primer extension technique. Three synthetic primers were used to sequence the central loop in domain V of 23 S rRNA, leading to identification of a C to U transition at position 2611. This base change was proved to be responsible for the erythromycin-resistance phenotype by the plasmid-plasmid marker rescue technique. A molecular explanation for the rrn mutations leading, respectively, to undissociated and to dissociated types of resistance to the MLSb (macrolide-lincosamide-synergimycin B) group of antibiotics is proposed. These results and some literature data support the notion that rRNA bases involved in antibiotic resistance play a conformational role in the ribosomal binding sites for the MLSb antibiotics.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569089

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori.

Authors:  Emiko Rimbara; Norihisa Noguchi; Takashi Kawai; Masanori Sasatsu
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

3.  Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.

Authors:  Annie Canu; Brigitte Malbruny; Maëlle Coquemont; Todd A Davies; Peter C Appelbaum; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.

Authors:  J I Ross; E A Eady; J H Cove; C E Jones; A H Ratyal; Y W Miller; S Vyakrnam; W J Cunliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Mechanism of action of streptogramins and macrolides.

Authors:  P Vannuffel; C Cocito
Journal:  Drugs       Date:  1996       Impact factor: 9.546

6.  The conformation of 23S rRNA nucleotide A2058 determines its recognition by the ErmE methyltransferase.

Authors:  B Vester; L H Hansen; S Douthwaite
Journal:  RNA       Date:  1995-07       Impact factor: 4.942

Review 7.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

8.  Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics.

Authors:  G Wang; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Chemobiosynthesis of new antimalarial macrolides.

Authors:  Christopher D Goodman; Mariana Useglio; Salvador Peirú; Guillermo R Labadie; Geoffrey I McFadden; Eduardo Rodríguez; Hugo Gramajo
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

10.  Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain.

Authors:  P Vannuffel; M Di Giambattista; C Cocito
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.